SignalbaseUpdated 12 Jul 2026

Top recently funded startups in Austria, week of 2026-07-06

Austria logged 3 verified funding rounds in the week ending 05 Jul 2026, totalling ≈$7.9M. SOMAREALITY anchors the week with a ≈$3.2M Series A in Hospitals and Health Care.

Week of 2026-07-06Austria3 deals≈$7.9M raised

Country	Austria
Deals this week	3
Total raised	≈$7.9M
Top sector	Biotechnology (1)
Most common round	Seed (1)
Sources tracked	8

The biggest 3 deals this week

#	Company	Amount	Round	Sector	Announced
1	SOMAREALITY	€3.0M	Series A	Hospitals and Health Care	01 Jun 2026
2	TradersYard	$2.5M	Seed	Financial Services	30 Jun 2026
3	Epitome Therapeutics	€2.0M	equity	Biotechnology	30 Jun 2026

Closer look at the top 3

SOMAREALITY

Announced 01 Jun 2026

€3.0M · Series A · Hospitals and Health Care · Austria

At SOMAREALITY, we specialize in developing algorithms based on eye-tracking data, revolutionizing the way we understand and monitor cognitive processes in real-time.

“SOMAREALITY raises €3M to redefine cognitive measurement through eye tracking technology | Vestbee Join here Join Vestbee Summer Pitch CEE Pitch to hundreds of VC funds and business angels Join here Join here News Insights Sectors Newsletter Events Platform News Insights Sectors Newsletter Events Vestbee Platform June 18, 2026 · 2 min read Joy Laou”
From the announcement · 29 Jun 2026

1 more source tracked. Read the full press release and reporter coverage.

Investors: Catalyst Romania Fund II (lead), MT-Lab, RDY Ventures, Moondust Ventures, Gateway Ventures.

TradersYard

Announced 30 Jun 2026

$2.5M · Seed · Financial Services · Austria

Most active investors this week

#	Investor	Deals
1	Austria Wirtschaftsservice (AWS)	1
2	Austrian Research Promotion Agency (FFG)	1
3	Caesar Ventures	1
4	Catalyst Romania Fund II	1
5	Gateway Ventures	1
6	Moondust Ventures	1
7	MT-Lab	1
8	Navec Venture Holding GmbH	1
9	RDY Ventures	1
10

What this week tells us

Biotechnology accounted for 1 of 3 verified deals in Austria this week. The stage mix was 1 early-stage (pre-seed to seed) against 2 Series A or later.